Summary of Key Points from the Conference Call Industry Overview - The conference call discusses the **AI in Healthcare** industry, highlighting the acceleration of AI medical orders and projects since the release of DeepSeek R1 in February 2024, marking a new growth phase for AI-enabled healthcare solutions [1][2]. Core Insights and Arguments 1. **Acceleration of AI Medical Orders**: - As of Q1 2025, over **100 hospitals** have deployed large models and related applications, with the release of WiNGPT2.8 based on DeepSeek [1]. - AI-related medical orders reached **488 million yuan** in 2024, representing a **106% year-over-year increase**. In Q1 2025, new AI medical contracts signed amounted to **139 million yuan**, showing a **211% year-over-year growth** [1]. - In 2024, there were **31 new IT orders** worth **580 million yuan**, and in Q1 2025, **8 new IT orders** were recorded, including AI large model deployments [1]. 2. **AI Medical Data Processing**: - By the end of 2024, the company's AI medical brain, YiduCore, processed over **5 billion medical records**, covering more than **1 billion patients** and serving **102 top hospitals** [1]. - The company provided AI digital solutions to over **80 hospitals** and produced over **3 million** pathology AI-assisted diagnostic reports, with "Di'an Smart Inspection" serving over **8,000 medical institutions** and **40,000 medical personnel** [1]. 3. **Trends and Policy Catalysts**: - The rapid iteration and innovation of domestic AI large models, such as DeepSeek, Alibaba's Qwen3, and Tencent's Turbo S, are crucial for driving AI applications across industries, potentially initiating a new IT construction cycle [1]. - The Ministry of Industry and Information Technology, along with six other departments, issued the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)" on April 24, emphasizing the need for AI empowerment in the pharmaceutical industry [2]. Additional Important Insights - The call suggests monitoring several companies involved in AI healthcare, including: - **Neusoft, Jiahe Meikang, Yidu Technology, Chuangye Huikang, Jiuyuan Yinhai, Guoxin Health, and Langma Information** for AI in healthcare [2]. - **AI in Pharmaceuticals**: Jingtai Holdings and Yingshi Intelligent (in IPO stage) [2]. - **AI in Health Management**: Meinian Health, Alibaba Health, JD Health, iFlytek Medical Technology, and Loxin Medical [2]. - **AI in Diagnostic Assistance**: Dian Diagnostics, Rundat Medical, Kingmed Diagnostics, BGI (medical group coverage), and Anbiping [2]. - **AI Digital Doctor Platforms**: Yimai Tong [2].

Company Overview - Sichuan Jiuyuan Yinhai Software Co., Ltd. focuses on three strategic directions: medical insurance, digital government, and smart cities, serving government departments and industry ecosystem entities [2] - The company utilizes technologies such as big data, cloud computing, blockchain, artificial intelligence, and mobile internet to empower people's livelihoods and assist in modernizing national governance systems [2] - Jiuyuan Yinhai is recognized as a national high-tech enterprise and has received multiple awards, including being listed among China's top 100 growth companies and top 30 in Sichuan's software and information technology services [2] Financial Performance - In the first quarter of 2025, the company achieved operating revenue of 208 million yuan, representing a year-on-year increase of 6.25% [3] - The net profit for the same period was 14.90 million yuan, up 17.18% year-on-year, with a gross profit margin of 45.26% [3] Market Position - As of May 6, the company's stock closed at 18.06 yuan, with a PE ratio of 97.72, marking a new low in 21 days [1] - The average PE ratio for the internet services industry is 77.55, with a median of 80.78, placing Jiuyuan Yinhai at the 110th position in the industry ranking [1][4] - The total market capitalization of the company is 7.373 billion yuan [1]

Group 1 - The National Bureau of Statistics emphasizes the importance of public data as a key resource in the data factor market, with potential value estimated between 10 trillion to 15 trillion yuan according to McKinsey [1] - The national data market transaction scale exceeds 160 billion yuan, showing a year-on-year growth of 30% [2] - Companies with data resource capabilities or data product development abilities are expected to benefit from the evolving public data operation authorization model [2] Group 2 - Companies providing data products/services include Shanghai Steel Union (bulk commodities), Tongxingbao (transportation), Jiuyuan Yinhai (medical insurance), and others [3] - Companies involved in data operation include Deep Sanda A, Shanda Diwei, Jiuyuan Yinhai, and others [3] - Companies engaged in data trading include Anheng Information, Guangdian Yuntong, and others [4]

证券代码：002777 证券简称：久远银海 公告编号：2025-018 四川久远银海软件股份有限公司 第六届监事会第八次会议决议的公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 四川久远银海软件股份有限公司（以下简称"公司"）第六届监事会第八次会议通知 于 2025 年 4 月 17 日以专人送达、传真、电话等方式发出。会议于 2025 年 4 月 28 日以通 讯形式召开。会议应参加表决的监事 5 人，实际参加表决的监事 5 人。会议由监事会主席 侯春梅女士主持，会议的召集和召开符合《公司法》以及《公司章程》的规定，会议决议 合法有效。经过全体监事充分讨论，以记名投票的方式审议通过议案并形成如下决议： 一、审议通过了《公司 2025 年第一季度报告》 经审核，与会监事认为，公司董事会编制和审核《公司 2025 年第一季度报告》（公告 编号：2025-019）的程序符合法律、行政法规和中国证监会的相关规定，报告内容真实、 准确、完整地反映了上市公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗 漏。 《公司 2025 年第一季度报告》（公告编号：2 ...

证券代码：002777 证券简称：久远银海 公告编号：2025-017 四川久远银海软件股份有限公司 第六届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 四川久远银海软件股份有限公司第六届董事会第十一次会议通知于 2025 年 4 月 17 日以专人送达、电话、电子邮件等方式送达全体董事、监事及全体高级管理人员。 会议于 2025 年 4 月 28 日以通讯方式召开，会议应参加表决的董事 9 人，实际参加 表决的董事 9 人。会议由董事长连春华先生主持，会议的召集、召开符合有关法律、 法规和《公司章程》的规定。 二、董事会会议审议情况 会议以记名投票方式对议案进行表决，审议通过如下议案： 1. 审议通过《公司 2025 年第一季度报告》 公司严格按照《证券法》《深圳证券交易所股票上市规则》及《公司章程》等有 关规定和要求，编制完成了《公司 2025 年第一季度报告》（公告编号：2025-019）。 具体内容详见《证券时报》《证券日报》《中国证券报》《上海证券报》及巨潮资讯网 （http://www.cni ...

一、市场指数 与成交额 ：缩量反弹，沪指收于 3300 点之下 今日， A 股三大指数延续震荡格局。截至收盘，上证指数 3295.06 点，下跌 0.07% ；深证 成指上涨 0.39% ，创业板指表现最强，涨幅 0.59% 。两市成交额合计 1.1 万亿元，市场交 投情绪趋于平淡。 从资金面看，央行今日开展 6000 亿元中期借贷便利（ MLF ）操作，净投放 5000 亿元流动 性，为市场注入信心。叠加中央汇金一季度增持沪深 300ETF 的稳定作用，市场下行风险被 有效对冲。 二、领涨板块：电力、 AI 医疗与算力概念活跃 电力板块：煤价下行叠加容量电价机制优化，火电企业盈利预期改善。华银电力、西昌电力等 涨停，机构预计 4 月全社会用电量增速或达 4.5%-5.5% 。 AI 医疗与算力概念：受工信部等七部门《医药工业数智化转型实施方案》推动， AI 医疗板块 活跃，塞力医疗、创业慧康等涨幅居前。算力产业链同步反弹，拓维信息、鸿博股份涨停，国 产算力需求激增成为长期增长逻辑。 四、 总结 当前市场仍处于震荡筑底阶段， 同时 政策托底与流动性宽松为结构性行情提供支撑 。期待 5 月出现新的行情。 欢迎大 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002777 证券简称：久远银海 公告编号：2025-016 四川久远银海软件股份有限公司 2024年年度股东大会决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 重要提示 1、本次股东大会无增加、变更、否决提案的情况； 2、本次股东大会不涉及变更以往股东大会已通过的决议； 3、本次会议议案均属于涉及影响中小投资者利益的重大事项，公司对中小投资者（指除单独或合计持 有公司5%以上股份的股东及公司董事、监事、高级管理人员以外的其他股东）的表决单独计票。 一、会议召开和出席情况 1、会议召开时间： （1）现场会议时间：2025年4月18日（星期五）下午14：30 （2）网络投票时间：2025年4月18日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为2025年4月18日上午9：15至9：25；9： 30-11：30和下午13：00-15：00；通过深圳证券交易所互联网投票的具体时间为：2025年4月18日上午 9：15至下午15：00期间的任意时间。 2、会议召开地点：四川省成都市锦江 ...

Investment Rating - Maintain "Outperform" rating with a target price adjustment to RMB 23.38 based on a 2025 PE of 60x [2][10] Core Insights - Significant improvement in cash flow and operational quality, with 2024 revenue at RMB 1.34 billion (-0.55%) and net profit attributable to shareholders at RMB 73 million (-55.96%) [2][10] - Operating net cash flow increased by 56.81% to RMB 295 million, indicating effective credit management and accounts receivable collection [2][10] - Q4 2024 revenue showed a growth of 23.53% to RMB 671 million, with net profit attributable to shareholders at RMB 54 million (+4.44%) [2][10] Contract Orders and Project Wins - Company won the Chongqing Hechuan District smart medical project with a contract value of RMB 91.73 million, enhancing its order book [3][10] - Additional contract with a subsidiary of China Academy of Engineering Physics valued at RMB 49.36 million, indicating steady growth in contract orders [3][10] Market Demand and Technological Development - Anticipated recovery in demand for medical and livelihood informatization, with a focus on enhancing product technology and service capabilities [4][10] - Leveraging self-developed models and platforms to support data governance and intelligent applications in the medical and governmental sectors [4][10] - Under the "Healthy China" and "Digital China" initiatives, the integration of AI and new technologies is expected to drive industry intelligence upgrades [4][10]

Company Overview - Sichuan Jiuyuan Yinhai Software Co., Ltd. focuses on three strategic directions: medical insurance, digital government, and smart cities, serving government departments and industry ecosystem entities [2] - The company utilizes technologies such as big data, cloud computing, blockchain, artificial intelligence, and mobile internet to empower people's livelihoods and assist in the modernization of the national governance system [2] - Jiuyuan Yinhai is recognized as a national high-tech enterprise and has received multiple awards, including being listed among China's top 100 growth companies and top 30 in Sichuan's software and information technology service industry [2] Financial Performance - In the latest financial report for 2024, the company achieved operating revenue of 1.339 billion yuan, a year-on-year decrease of 0.55% [3] - The net profit for the same period was 73.2613 million yuan, reflecting a significant year-on-year decline of 55.96% [3] - The sales gross margin stood at 41.37% [3] Market Position - As of April 9, the company's stock closed at 16.26 yuan, with a price-to-earnings (PE) ratio of 90.61, significantly higher than the industry average of 62.03 [1][3] - The total market capitalization of Jiuyuan Yinhai is 6.638 billion yuan [1] - The company ranks 117th in terms of PE ratio within the internet services industry [1]

Company Overview - Sichuan Jiuyuan Yinhai Software Co., Ltd. focuses on three strategic directions: medical insurance, digital government, and smart cities, serving government departments and industry ecosystem entities [2] - The company utilizes technologies such as big data, cloud computing, blockchain, artificial intelligence, and mobile internet to empower people's livelihoods and support the modernization of national governance systems [2] - Jiuyuan Yinhai is recognized as a national high-tech enterprise and has received multiple awards, including being listed among China's top ten innovative software companies [2] Financial Performance - For the fiscal year 2024, the company reported operating revenue of 1.339 billion yuan, a year-on-year decrease of 0.55%, and a net profit of 73.2613 million yuan, down 55.96% year-on-year [3] - The company's gross profit margin stands at 41.37% [3] Market Position - As of April 3, the company's stock closed at 17.9 yuan, with a rolling price-to-earnings (PE) ratio of 99.74, significantly higher than the industry average PE of 68.46 [1][3] - Jiuyuan Yinhai's total market capitalization is 7.307 billion yuan, ranking 116th in the internet services industry [1][3] Shareholder Information - As of February 28, 2025, the number of shareholders in Jiuyuan Yinhai has increased to 59,848, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]